Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docusate sodium for repeat bowel preparation after initial bowel preparation failure
ChiCTR2200063339Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Sep 2022
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of docusate sodium, macrogol and bisacodyl in inadequate bowel preparation (IBP) (3 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Time to reach the ileocecal valve, Colonoscopy withdrawal time and 5 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
docusate sodiummacrogolbisacodyl
03
Conditions
inadequate bowel preparation (IBP)
Beyond the preview
Go deeper on ChiCTR2200063339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063339.